| Dr Tatsuro Ogisu, MD | |
|
2455 Nw Marshall St, Suite 6, Portland, OR 97210-2949 | |
| (503) 706-9445 | |
| (503) 282-6812 |
| Full Name | Dr Tatsuro Ogisu |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 2455 Nw Marshall St, Portland, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902940505 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | MD21453 (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tatsuro Ogisu, MD 2455 Nw Marshall St, Suite 6, Portland, OR 97210-2949 Ph: (503) 706-9445 | Dr Tatsuro Ogisu, MD 2455 Nw Marshall St, Suite 6, Portland, OR 97210-2949 Ph: (503) 706-9445 |
News Archive
University of Missouri Health Care has received the global HIMSS Enterprise Nicholas E. Davies Award of Excellence for health care technology innovations that are improving patient outcomes.
Kayo Fujimoto, Ph.D., assistant professor in the Center for Health Promotion and Prevention Research at The University of Texas Health Science Center at Houston School of Public Health, has been awarded a grant to study the genetic and social network aspects of human immunodeficiency virus (HIV) transmission.
Randomised Controlled Trials (RCTs) are considered the 'gold standard' research method for assessing new medical treatments. But research published in BioMed Central's open access journal Trials shows that the design of a remarkable 93 percent of 2235 so-called RCTs published in some Chinese medical journals during 1994 to 2005 was flawed, casting doubt on the reliability of research that is likely to influence medical decision-makers.
Ocera Therapeutics, Inc. presented an analysis of the prevalence of neurocognitive impairment in ambulatory cirrhotic patients. The data came from the screening period of the ASTUTE Study, an ongoing Phase 2b study evaluating the safety and efficacy of AST-120 (spherical carbon adsorbent) in the treatment of mild hepatic encephalopathy (MHE). The poster was presented yesterday at the annual meeting of the European Association for the Study of Liver (EASL) in Vienna, Austria. Efficacy and safety data from the ASTUTE study are expected in the summer of 2010.
› Verified 5 days ago
Danielle Laure Erb, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1815 Sw Marlow Ave, Suite 110, Portland, OR 97225 Phone: 503-296-0918 Fax: 503-296-6158 | |
Dr. Duncan Soule, M.D. Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 2617 Nw Thurman St, Portland, OR 97210 Phone: 503-224-9010 Fax: 503-224-5551 | |
Dr. Stephanie K Liu, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 10940 Sw Barnes Rd # 375, Portland, OR 97225 Phone: 646-591-7011 | |
Thomas Lorish, MD Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 9155 Sw Barnes Rd, #440, Portland, OR 97225 Phone: 503-216-7145 Fax: 503-216-4071 | |
Dr. Lynette Santos Malik, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 3600 N Interstate Ave, Department Of Physical Medicine, Portland, OR 97227 Phone: 503-331-3070 Fax: 503-331-3089 | |
Dr. Gary Allen Ward, M.D. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 1040 Nw 22nd Ave, Suite 320, Portland, OR 97210 Phone: 503-413-6294 Fax: 503-413-7780 | |
Steven James Janselewitz, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2801 N Gantenbein Ave, Portland, OR 97227 Phone: 503-413-4505 |